Angiotensin II increases CTGF expression via MAPKs/TGF-Β1/TRAF6 pathway in atrial fibroblasts

Experimental Cell Research

Volumn 318, Issue 16, 2012, Pages 2105-2115

  Gu, Jun ^a   Liu, Xu ^a   Wang, Quan xing ^b   Tan, Hong wei ^a   Guo, Meng ^b   Jiang, Wei feng ^a   Zhou, Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Atrial fibroblasts; CTGF; MAPKs; TGF 1; TRAF6

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CONNECTIVE TISSUE GROWTH FACTOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART ATRIUM; HEART MUSCLE FIBROSIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RNA INTERFERENCE;

EID: 84864320125     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.06.015     Document Type: Article

References (32)

1. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 2002, 54:230-246.
2. Tan A.Y., Zimetbaum P. Atrial fibrillation and atrial fibrosis. J. Cardiovasc. Pharmacol. 2011, 57:625-629.
3. Novo G., Guttilla D., Fazio G., Cooper D., Novo.S. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS. Br. J. Clin. Pharmacol. 2008, 66:345-351.
4. Kupfahl C., Pink D., Friedrich K., Zurbrügg H.R., Neuss M., Warnecke C., Fielitz J., Graf K., Fleck E., Regitz-Zagrosek V. Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc. Res. 2000, 46:463-475.
5. Ko W.C., Hong C.Y., Hou S.M., Lin C.H., Ong E.T., Lee C.F., Tsai C.T., Lai L.P. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes. Circ. J. 2011, 75:1592-1600.
6. Tsai C.T., Tseng C.D., Hwang J.J., Wu C.K., Yu C.C., Wang Y.C., Chen W.P., Lai L.P., Chiang F.T., Lin J.L. Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor beta1. Cardiovasc. Res. 2011, 89:805-815.
7. Li L., Fan D., Wang C., Wang J.Y., Cui X.B., Wu D., Zhou Y., Wu L.L. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-Β1 pathways in cardiac fibroblasts. Cardiovasc. Res. 2011, 91:80-89.
8. Naito T., Masaki T., Nikolic-Paterson D.J., Tanji C., Yorioka N., Kohno N. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am. J. Physiol. Renal. Physiol. 2004, 286:F278-287.
9. Liu B., Yu J., Taylor L., Zhou X., Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J. Cell Biochem. 2006, 97:1104-1120.
10. He X., Gao X., Peng L., Wang S., Zhu Y., Ma H., Lin J., Duan D.D. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ. Res. 2011, 108:164-175.
11. Gramley F., Lorenzen J., Koellensperger E., Kettering K., Weiss C., Munzel T. Atrial fibrosis and atrial fibrillation: the role of the TGF-Β1 signaling pathway. Int. J. Cardiol. 2010, 143:405-413.
12. Yamashita M., Fatyol K., Jin C., Wang X., Liu Z., Zhang.Y.E. TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-Β. Mol. Cell 2008, 31:918-924.
13. Mao R., Fan Y., Mou Y., Zhang H., Fu S., Yang J. TAK1 lysine 158 is required for TGF-Β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation. Cell. Signal 2011, 23:222-227.
14. Xiao H.D., Fuchs S., Campbell D.J., Lewis W., Dudley S.C., Kasi V.S., Hoit B.D., Keshelava G., Zhao H., Capecchi M.R., Bernstein K.E. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am. J. Pathol. 2004, 165:1019-1032.
15. Boldt A., Wetzel U., Weigl J., Garbade J., Lauschke J., Hindricks G., Kottkamp H., Gummert J.F., Dhein S. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J. Am. Coll. Cardiol. 2003, 42:1785-1792.
16. Nakashima H., Kumagai K. Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model. Circ. J. 2007, 71:1977-1982.
17. Huang G., Xu J.B., Liu J.X., He Y., Nie X.L., Li Q., Hu Y.M., Zhao S.Q., Wang M., Zhang W.Y., Liu X.R., Wu T., Arkin A., Zhang T.J. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis. Eur. J. Clin. Invest. 2011, 41:719-733.
18. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol. Genet. Metab. 2000, 71:418-435.
19. Khan R., Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006, 118:10-24.
20. Evans R.A., Tian Y.C., Steadman R., Phillips A.O. TGF-beta1-mediated fibroblastmyofibroblast terminal differentiation-the role of SMAD proteins. Exp. Cell Res. 2003, 282:90-100.
21. Landström M. The TAK1-TRAF6 signalling pathway. Int. J. Biochem. Cell Biol. 2010, 42:585-589.
22. Watkins S.J., Borthwick G.M., Oakenfull R., Robson A., Arthur H.M. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. Hypertens. Res. 2011, 10.1038.
23. Doyon P., Servant M.J. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells. J. Biol. Chem. 2010, 285:30708-30718.
24. Stockand J.D., Meszaros J.G. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H176-H184.
25. He Y.H., Zhang H.N., Zhang G.P., Hou N., Xiao Q., Huang Y., Wu J.H., Luo M.S., Zhang G.S., Yi Q., Chen M.S., Luo J.D. A physiological concentration of glucocorticoid inhibits the pro-inflammatory cytokine-induced proliferation of adult rat cardiac fibroblasts: roles of extracellular signal-regulated kinase 1/2 and nuclear factor-κB. Clin. Exp. Pharmacol. Physiol. 2011, 38:739-746.
26. Tsushima K., Osawa T., Yanai H., Nakajima A., Takaoka A., Manabe I., Ohba Y., Imai Y., Taniguchi T., Nagai R. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension. FASEB. J. 2011, 25:1531-1543.
27. Adam O., Lavall D., Theobald K., Hohl M., Grube M., Ameling S., Sussman M.A., Rosenkranz S., Kroemer H.K., Schäfers H.J., Böhm M., Laufs U. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J. Am. Coll. Cardiol. 2010, 55:469-480.
28. Adam O., Theobald K., Lavall D., Grube M., Kroemer H.K., Ameling S., Schäfers H.J., Böhm M., Laufs U. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation. J. Mol. Cell Cardiol. 2011, 50:678-685.
29. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Tseng Y.Z., Chiang F.T., Lin J.L. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
30. Yang J., Tan Y., Zhao F., Ma Z., Wang Y., Zheng S., Epstein P.N., Yu J., Yin X., Zheng Y., Li X., Miao L., Cai L. Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E132-144.
31. Huang H., Kim H.J., Chang E.J., Lee Z.H., Hwang S.J., Kim H.M., Lee Y., Kim.H.H. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009, 16:1332-1343.
32. Li Q., Harraz M.M., Zhou W., Zhang L.N., Ding W., Zhang Y., Eggleston T., Yeaman C., Banfi B., Engelhardt.J.F. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell Biol. 2006, 26:140-154.